Skip to content

13F-HR filed by Nextech Invest Ltd.

Nextech Invest Ltd. filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:29:04 UTC, with 18 holding rows worth $2,232,309,227.

Accession
0001595430-26-000015
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 18 entries on the cover page, a total value of $2,232,309,227 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,232,309,227 with VALUE read as dollars as filed, 13F file number 028-25607. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
REVOLUTION MEDICINES INC COM76155X100Stock7,601,087$1,560,199,118dollars as filed
PARABILIS MEDICINES INC COM698955101Stock4,663,176$150,573,953dollars as filed
RELAY THERAPEUTICS INC COM75943R102Stock6,776,506$122,315,933dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM7,162,637$96,480,720dollars as filed
TYRA BIOSCIENCES INC90240B106COMMON STOCK3,447,482$75,396,431dollars as filed
ALUMIS INC022307102COM4,550,998$33,631,875dollars as filed
ATTOVIA THERAPEUTICS INC04987L102COM1,835,139$31,454,282dollars as filed
KYMERA THERAPEUTICS INC501575104COM278,896$31,177,784dollars as filed
Electra Therapeutics, Inc.284825106Common Stock, $0.0001 par value per share2,636,225$29,657,531dollars as filed
ZYMEWORKS INC98985Y108COM1,113,946$29,508,430dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS1,693,140$18,506,020dollars as filed
CYTOMX THERAPEUTICS INC23284F105COMMON STOCK4,449,932$12,103,815dollars as filed
AVALO THERAPEUTICS INC05338F306COMMON STOCK766,000$11,742,780dollars as filed
MONTE ROSA THERAPEUTICS INC61225M102COM761,153$9,080,555dollars as filed
Braveheart Bio Inc10567X101COM416,700$8,417,340dollars as filed
CORVUS PHARMACEUTICALS INC221015100COM450,000$5,184,000dollars as filed
ENGENE THERAPEUTICS INC29286X101COM2,324,943$4,649,886dollars as filed
CONTEXT THERAPEUTICS INC21077P108COM7,419,355$2,228,774dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001595430-26-000015this filing2026-11-16